Riccardo Galbusera

15PUBLICATIONS
84CO-AUTHORS
Peripheral nervous systemNeurology and neuromuscular diseasesMedical infection agents (incl. prions)Regenerative medicine (incl. stem cells)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Nov 14, 2025
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosis.

Aleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler

|Aug 04, 2025
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment Response.

Maximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren

|Apr 14, 2025
Quantitative T1 is sensitive to cortical remyelination in multiple sclerosis: A postmortem MRI study.

Riccardo Galbusera, Matthias Weigel, Erik Bahn

|Feb 28, 2025
Treatment persistence and clinical outcomes in patients starting B cell depleting therapies within the Swiss MS Cohort.

Giulio Disanto, Sabine Schaedelin, Johanna Oechtering

|Jan 03, 2025
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple Sclerosis.

Johanna Oechtering, Sabine Anna Schaedelin, Kerstin Stein

|Oct 16, 2024
Serum Glial Fibrillary Acidic Protein and Neurofilament Light Chain Levels Reflect Different Mechanisms of Disease Progression under B-Cell Depleting Treatment in Multiple Sclerosis.

Pascal Benkert, Aleksandra Maleska Maceski, Sabine Schaedelin

Pageof 3

Frequent Collaborators

9 joint publications

Alessandro Cagol

8 joint publications

Ludwig Kappos

8 joint publications

Jens Kuhle

8 joint publications

Cristina Granziera